MedPath

Sulindac

Sulindac Tablets USP, 150 mg and 200 mgRx only

Approved
Approval ID

ddbbaada-f55a-4032-a24c-a8c493933a45

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 25, 2021

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sulindac

PRODUCT DETAILS

NDC Product Code50090-4976
Application NumberANDA072711
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateApril 22, 2019
Generic NameSulindac

INGREDIENTS (5)

SULINDACActive
Quantity: 200 mg in 1 1
Code: 184SNS8VUH
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K29/32Inactive
Code: 390RMW2PEQ
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sulindac - FDA Drug Approval Details